Related Posts

Rankings Of Published Price-Earnings Ratios And Value Investor Attention
By VW Staff
Rankings Of Published Price-Earnings Ratios And Value Investor Attention Jordan Moore University of Rochester, Simon Business School, Students June 22, 2016 Abstract: Price-earnings (P/E) ratios are the most popular proxy for fundamental... read more
All Hedge Funds Selling Stock Into Uncertainty
Investors are taking money off the table ahead of the US presidential election according to JP Morgan’s most recent Flows & Liquidity report. Self-Learning Machines Beating Hedge Funds Activist Hedge Funds... read more

5 Insights From The 2019 Berkshire Hathaway Annual Meeting
Warren Buffett and Charlie Munger provided many insights when they answered questions for nearly 6 hours on Saturday, May 4th, during the 2019 Berkshire Hathaway Annual Meeting. The following... read more

Project Independence: Possible This Year If US Petroleum Production Continues To Ramp Up
By Guest Post
The US shale boom has led to a surge in the production of crude oil, and much of this production has been exported in recent years. In the chart... read more

Aswath Damodaran: Valuations – The Grand Finale
By VW Staff
In this session, Aswath Damodaran reviews the material for the class using Dante's Inferno as a guide. We then look at the class using the project findings as lens. Aswath... read more

Josh Brooks: Investing Versus Speculating
By VW Staff
Investing Versus Speculating, with Josh Brooks of Granite House Capital Management read more

China's Re-balancing of Economy Might be Working
By VW Staff
China recently released March numbers that showed the country had an increase in exports and slowdown in imports, creating a trade surplus. However, there may be more than what... read more

UTIMCO Board of Directors 20th Anniversary Event – Dalio, Burbank, Griffin, Others
By VW Staff
UTIMCO Board of Directors 20th Anniversary Event - March 3, 2016 Some top speakers today - see below for the line-up Created in March 1996, UTIMCO is the first external... read more

Bristol Myers Squibb Co. to buy Amylin For $7 billion
By VW Staff
Bristol Myers Squibb Co. (NYSE:BMY) hopes to expand its diabetes franchise after it agreed to buy Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) at a price close to $7 billion-this all happened on Friday in... read more

Are You Ready for Higher Inflation?
For most of the last 20 years, advisors could safely ignore inflation and the risks it posed to their clients’ fixed-income holdings and earning power. But inflation is too... read more
LEAVE A COMMENT
You must be logged in to post a comment.